JMP Securities Reiterates a Hold Rating on U.S. Physical TherapyBy Jason Carr
According to TipRanks.com, Martin is a 1-star analyst with an average return of -5.3% and a 44.4% success rate. Martin covers the Financial sector, focusing on stocks such as Senior Housing Properties Trust, National Health Investors, and MedEquities Realty Trust.
Currently, the analyst consensus on U.S. Physical Therapy is Moderate Buy and the average price target is $61, representing a 9.2% upside.
In a report released today, Jefferies also maintained a Hold rating on the stock with a $60 price target.
U.S. Physical Therapy’s market cap is currently $694.9M and has a P/E ratio of 28.50. The company has a book value ratio of 3.8869.
Based on the recent corporate insider activity of 30 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of USPH in relation to earlier this year. Most recently, in May 2016, Regg Swanson, a Director at USPH sold 3,000 shares for a total of $171,870.
U.S. Physical Therapy, Inc. operates outpatient physical therapy clinics that provide preventative and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The company was founded in 1990 and is headquartered in Houston, TX.